CG
CODX

Cutler Group’s Co-Diagnostics CODX Stock Holding History

Cutler Group’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-27
Closed -$3K – 5756
2021
Q1 		$3K Sell
27
-136
-83% -$54.3K ﹤0.01% 4660
2020
Q4 		$27K Sell
163
-207
-56% -$76.7K ﹤0.01% 2452
2020
Q3 		$64K Buy
370
+87
+31% +$44.7K ﹤0.01% 1626
2020
Q2 		$62K Hold
283
– – ﹤0.01% 1606
2020
Q1 		$41K Buy
+283
New +$49.1K ﹤0.01% 1843

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Cutler Group's CODX Position: Q1 2023 in Review

Cutler Group sold out of Co-Diagnostics (CODX) in Q1 2023, closing a stake of 5 shares.

Cutler Group first reported a position in CODX in Q1 2020 and held it in 12 quarters. The position peaked at $127K in Q2 2020. 51 funds tracked by Wall St. Rank hold CODX as of Q1 2023.

  • Cutler Group reported no remaining Co-Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 5 Co-Diagnostics shares in Q1 2023.
  • Cutler Group first reported a position in Co-Diagnostics in Q1 2020 and held it in 12 quarters.
  • Cutler Group's Co-Diagnostics position peaked at $127K in Q2 2020.
  • 51 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.